Automate Your Wheel Strategy on PHAR
With Tiblio's Option Bot, you can configure your own wheel strategy including PHAR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PHAR
- Rev/Share 0.4796
- Book/Share 0.3218
- PB 3.2108
- Debt/Equity 0.5567
- CurrentRatio 2.7614
- ROIC -0.0048
- MktCap 698677343.0
- FreeCF/Share 0.0077
- PFCF 136.2422
- PE -48.7558
- Debt/Assets 0.2955
- DivYield 0
- ROE -0.0647
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | PHAR | Jefferies | -- | Buy | -- | $14 | Dec. 9, 2024 |
News
Pharming Group N.V. (PHAR) Q1 2025 Earnings Call Transcript
Published: May 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Pharming Group N.V. (NASDAQ:PHAR ) Q1 2025 Earnings Conference Call May 8, 2025 7:30 AM ET Company Participants Fabrice Chouraqui – CEO Stephen Toor – CCO Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Conference Call Participants Jeff Jones – Oppenheimer Joe Pantginis - H.C.
Read More
Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders
Published: March 04, 2025 by: GlobeNewsWire
Sentiment: Neutral
Leiden, the Netherlands, March 4, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today that the Extraordinary General Meeting of Shareholders (EGM) has adopted all proposals on the EGM agenda.
Read More
About Pharming Group N.V. (PHAR)
- IPO Date 2020-12-23
- Website https://www.pharming.com
- Industry Biotechnology
- CEO Fabrice Chouraqui
- Employees 404